Sumitomo Chemical India Limited has informed the stock exchanges that a meeting of its Board of Directors is scheduled to be held on Tuesday, May 26, 2026. The intimation was made in accordance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's scrip code is 542920, and it is listed under the symbol SUMICHEM.

Agenda for the Board Meeting

The primary agenda for the upcoming board meeting includes two key items. First, the directors will consider the audited financial statements of the company, both standalone and consolidated, for the financial year ended March 31, 2026. Second, the board will deliberate on the recommendation of a dividend, if any, on equity shares for the financial year 2025-26.

Key Details

The intimation was addressed to the Listing Departments of BSE Limited and The National Stock Exchange of India. The communication was signed by Deepika Trivedi, Company Secretary & Compliance Officer, on behalf of Sumitomo Chemical India Limited.

Sumitomo Chemical Company Limited has submitted a regulatory declaration to Indian stock exchanges confirming that no encumbrance exists on its substantial shareholding in Sumitomo Chemical India Limited. The declaration, dated April 3, 2026, was filed with both BSE Limited and the National Stock Exchange of India Ltd.

Regulatory Compliance Declaration

The Japanese parent company declared pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 that no direct or indirect encumbrance has been created on its shareholding in the Indian subsidiary. This regulatory requirement ensures transparency in substantial shareholdings and any potential restrictions on share transfers.

Shareholding Details

Filing Authority and Documentation

The declaration was signed by Tomohito Fujiwara, General Manager of Planning and Coordination Office, Agro & Life Solutions Sector at Sumitomo Chemical Co., Ltd., from Tokyo, Japan. The communication was addressed to the Corporate Relationship Department of BSE Limited and the Listing Department of National Stock Exchange of India Ltd.

Stock Exchange Communications

The filing included copies to Sumitomo Chemical India Limited and the Chairman of its Audit Committee at their registered office in Mumbai. The Indian subsidiary is listed on both major Indian stock exchanges with scrip codes 542920 on BSE and SUMICHEM on NSE.

This declaration represents routine regulatory compliance for substantial shareholders in Indian listed companies, ensuring market transparency regarding any potential restrictions on share transfers or voting rights.